Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ABBV

AbbVie

$79.94

-1.29 (-1.59%)

, AGN

Allergan

$149.70

-3.84 (-2.50%)

09:00
03/25/19
03/25
09:00
03/25/19
09:00
Conference/Events
Academy of Managed Care Pharmacy to hold annual meeting »

Managed Care &…

ABBV

AbbVie

$79.94

-1.29 (-1.59%)

AGN

Allergan

$149.70

-3.84 (-2.50%)

AMRN

Amarin

$17.64

-1.13 (-6.02%)

AZN

AstraZeneca

$42.58

-0.37 (-0.86%)

BAYRY

Bayer

$0.00

(0.00%)

BIIB

Biogen

$217.29

-9.42 (-4.16%)

NVO

Novo Nordisk

$50.70

-1.495 (-2.86%)

LLY

Eli Lilly

$128.30

0.08 (0.06%)

PODD

Insulet

$97.74

-4.15 (-4.07%)

INSM

Insmed

$28.21

-0.99 (-3.39%)

GILD

Gilead

$64.07

-0.85 (-1.31%)

TEVA

Teva

$16.35

-0.73 (-4.27%)

TSRO

Tesaro

$0.00

(0.00%)

DNA

Bought by RHHBY

$0.00

(0.00%)

SYNH

Syneos Health

$50.35

-1.78 (-3.41%)

SUPN

Supernus

$35.64

-2.1 (-5.56%)

CVS

CVS Health

$56.05

-1.35 (-2.35%)

SNSS

Sunesis

$1.30

0.34 (35.42%)

AIPT

Precision Therapeutics

$0.82

-0.005 (-0.61%)

CHRS

Coherus Biosciences

$14.32

-1.18 (-7.61%)

CELG

Celgene

$88.34

-1.28 (-1.43%)

WTKWY

Wolters Kluwer

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 12

    Apr

  • 24

    Apr

  • 30

    Apr

  • 30

    Apr

  • 01

    May

  • 18

    May

  • 28

    May

  • 27

    Jun

  • 03

    Sep

  • 04

    Nov

Over a week ago
GLYC

GlycoMimetics

$11.71

-0.21 (-1.76%)

, GSK

GlaxoSmithKline

$40.36

0.08 (0.20%)

16:33
03/05/19
03/05
16:33
03/05/19
16:33
Hot Stocks
GlycoMimetics board chair Jim Barrett will not seek re-election »

GlycoMimetic (GLYC)…

GLYC

GlycoMimetics

$11.71

-0.21 (-1.76%)

GSK

GlaxoSmithKline

$40.36

0.08 (0.20%)

TSRO

Tesaro

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

  • 18

    May

Over a month ago
ZLAB

Zai Lab

$25.70

0.17 (0.67%)

, TSRO

Tesaro

$0.00

(0.00%)

07:35
01/28/19
01/28
07:35
01/28/19
07:35
Hot Stocks
Zai Lab receives priority review status for Zejula NDA from NMPA »

Zai Lab (ZLAB) announced…

ZLAB

Zai Lab

$25.70

0.17 (0.67%)

TSRO

Tesaro

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSRO

Tesaro

$74.96

(0.00%)

08:30
01/23/19
01/23
08:30
01/23/19
08:30
Options
Two option delistings on January 23rd »

Option delistings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZLAB

Zai Lab

$22.84

0.21 (0.93%)

, TSRO

Tesaro

$74.36

-0.26 (-0.35%)

07:45
01/09/19
01/09
07:45
01/09/19
07:45
Hot Stocks
Zai Lab completes enrollment in niraparib Phase 3 trial »

Zai Lab (ZLAB) announced…

ZLAB

Zai Lab

$22.84

0.21 (0.93%)

TSRO

Tesaro

$74.36

-0.26 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

  • 17

    Jan

Over a quarter ago
CLVS

Clovis

$19.59

-1.16 (-5.59%)

, TSRO

Tesaro

$73.82

0.08 (0.11%)

13:28
12/17/18
12/17
13:28
12/17/18
13:28
Periodicals
Activist Armistice pushes Clovis to explore sale, Bloomberg reports »

Clovis Oncology's…

CLVS

Clovis

$19.59

-1.16 (-5.59%)

TSRO

Tesaro

$73.82

0.08 (0.11%)

GSK

GlaxoSmithKline

$37.21

-0.4 (-1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLVS

Clovis

$20.16

-1.48 (-6.84%)

, TSRO

Tesaro

$73.95

-0.51 (-0.68%)

11:28
12/14/18
12/14
11:28
12/14/18
11:28
On The Fly
Clovis drops after Tesaro filing shows interest, but no bids »

Shares of Clovis Oncology…

CLVS

Clovis

$20.16

-1.48 (-6.84%)

TSRO

Tesaro

$73.95

-0.51 (-0.68%)

GSK

GlaxoSmithKline

$37.60

-0.34 (-0.90%)

RHHBY

Roche

$0.00

(0.00%)

AZN

AstraZeneca

$39.07

-0.16 (-0.41%)

BMY

Bristol-Myers

$53.06

-0.59 (-1.10%)

SNY

Sanofi

$44.17

-0.67 (-1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Dec

  • 29

    Dec

  • 17

    Jan

  • 24

    Jan

  • 28

    Jan

  • 11

    Mar

  • 18

    Mar

  • 22

    Mar

  • 28

    Apr

  • 20

    May

CLVS

Clovis

$20.05

-1.59 (-7.35%)

, TSRO

Tesaro

$73.97

-0.49 (-0.66%)

11:03
12/14/18
12/14
11:03
12/14/18
11:03
Recommendations
Clovis, Tesaro, GlaxoSmithKline analyst commentary at Leerink »

Tesaro proxy documents…

CLVS

Clovis

$20.05

-1.59 (-7.35%)

TSRO

Tesaro

$73.97

-0.49 (-0.66%)

GSK

GlaxoSmithKline

$37.55

-0.39 (-1.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSK

GlaxoSmithKline

$37.68

0.31 (0.83%)

, AZN

AstraZeneca

$38.91

0.28 (0.72%)

08:06
12/13/18
12/13
08:06
12/13/18
08:06
Conference/Events
UBS pharmaceutical analyst to hold an analyst/industry conference call »

Pharmaceuticals Analyst…

GSK

GlaxoSmithKline

$37.68

0.31 (0.83%)

AZN

AstraZeneca

$38.91

0.28 (0.72%)

TSRO

Tesaro

$74.30

-0.05 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLVS

Clovis

$22.30

0.55 (2.53%)

, TSRO

Tesaro

$73.99

-0.08 (-0.11%)

10:43
12/11/18
12/11
10:43
12/11/18
10:43
Recommendations
Clovis, Tesaro, GlaxoSmithKline, Bristol-Myers, Sanofi, Roche analyst commentary at Gabelli »

Gabelli sees Clovis as…

CLVS

Clovis

$22.30

0.55 (2.53%)

TSRO

Tesaro

$73.99

-0.08 (-0.11%)

GSK

GlaxoSmithKline

$37.88

0.2 (0.53%)

BMY

Bristol-Myers

$53.05

0.46 (0.87%)

SNY

Sanofi

$44.70

0.53 (1.20%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 13

    Dec

  • 24

    Dec

  • 29

    Dec

  • 17

    Jan

  • 24

    Jan

  • 28

    Jan

  • 11

    Mar

  • 18

    Mar

  • 22

    Mar

  • 28

    Apr

  • 20

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.